Atea Pharmaceuticals is a clinical-stage biopharmaceutical enterprise dedicated to discovering and developing advanced oral antiviral therapeutics to treat serious viral infections. The company's scientific focus centers on targeting ribonucleic acid (RNA) polymerases to address global public health needs.